DELVING INTO THE FINANCIAL LANDSCAPE OF STEM CELL THERAPY

The sector of stem cell therapy is experiencing rapid development, attracting both significant investment and growing public attention. This multifaceted financial landscape is shaped by a spectrum of variables, including regulatory frameworks, clinical trial costs, and the dynamic demands of the consumer base. Understanding this terrain is crucial

Glaucoma, a condition that damages the optic nerve and can lead to vision loss, often requires surgical intervention. Fortunately, minimally invasive glaucoma surgery (MIGS) offers a less disruptive alternative to traditional procedures. These approaches involve small incisions and minimal tissue manipulation, resulting in quicker recovery times, r